Dawn Svoronos, Director at PTC THERAPEUTICS, INC. (PTCT), bought 25,000 shares at $13.49 ($337K) on 2017-05-23, disclosed to the SEC on 2017-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| GBT | SELL | 2022-06-22 | $104K | — | Filing → |
| PTCT | SELL | 2022-06-10 | $20K | — | Filing → |
| ADVM | BUY | 2022-05-18 | $26K | — | Filing → |